These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33506145)

  • 21. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of the health and economic burden of neurocysticercosis in India.
    Singh BB; Khatkar MS; Gill JP; Dhand NK
    Acta Trop; 2017 Jan; 165():161-169. PubMed ID: 26802489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present status of laboratory diagnosis of human taeniosis/cysticercosis in Europe.
    Gómez-Morales MA; Gárate T; Blocher J; Devleesschauwer B; Smit GSA; Schmidt V; Perteguer MJ; Ludovisi A; Pozio E; Dorny P; Gabriël S; Winkler AS
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2029-2040. PubMed ID: 28669015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocysticercosis presented as a solitary cystic parenchymal lesion mimicking primary brain tumor: A case report.
    Soejitno A; Niryana IW; Sriwidyani NP; Susilawathi NM; Witari NP; Sudewi AAR
    IDCases; 2020; 22():e01004. PubMed ID: 33204635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-five years of evolution of standard diagnostic criteria for neurocysticercosis. How have they impacted diagnosis and patient outcomes?
    Del Brutto OH
    Expert Rev Neurother; 2020 Feb; 20(2):147-155. PubMed ID: 31855080
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessing the burden and spatial distribution of Taenia solium human neurocysticercosis in Ecuador (2013-2017).
    Coral-Almeida M; Henriquez-Trujillo AR; Asanza S; Erazo C; Paucar M; Calvopiña M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008384. PubMed ID: 32511228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenytoin-associated movement disorder: A literature review.
    Rissardo JP; Caprara ALF
    Tzu Chi Med J; 2022; 34(4):409-417. PubMed ID: 36578637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the societal cost of Taenia solium in Angónia district, Mozambique.
    Trevisan C; Devleesschauwer B; Praet N; Pondja A; Assane YA; Dorny P; Thamsborg SM; Magnussen P; Johansen MV
    BMC Infect Dis; 2018 Mar; 18(1):127. PubMed ID: 29534702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Study of Paired Serum and Cerebrospinal Fluid Samples from Neurocysticercosis Patients for the Detection of Specific Antibody to Taenia solium Immunodiagnostic Antigen.
    Sako Y; Takayanagui OM; Odashima NS; Ito A
    Trop Med Health; 2015 Sep; 43(3):171-6. PubMed ID: 26543392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taenia solium cysticercosis and taeniasis in urban settings: Epidemiological evidence from a health-center based study among people with epilepsy in Dar es Salaam, Tanzania.
    Schmidt V; O'Hara MC; Ngowi B; Herbinger KH; Noh J; Wilkins PP; Richter V; Kositz C; Matuja W; Winkler AS
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007751. PubMed ID: 31809501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buspirone-associated Movement Disorder: A Literature Review.
    Rissardo JP; Caprara ALF
    Prague Med Rep; 2020; 121(1):5-24. PubMed ID: 32191616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of cerebral cysticercosis in an Andean community in Ecuador].
    Cruz ME; Preux PM; Debrock C; Cruz I; Schantz PM; Tsang VC; Dumas M
    Bull Soc Pathol Exot; 1999 Feb; 92(1):38-41. PubMed ID: 10214520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal cysticercosis. Case report and review.
    Isidro-Llorens A; Dachs F; Vidal J; Sarrias M
    Paraplegia; 1993 Feb; 31(2):128-30. PubMed ID: 8446458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocysticercosis: A case study of a Mongolian traveler who visited China and India with an updated review in Asia.
    Davaasuren A; Davaajav A; Ukhnaa B; Purvee A; Unurkhaan S; Luvsan A; Logan JE; Ito A
    Travel Med Infect Dis; 2017; 20():31-36. PubMed ID: 28478337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocysticercosis.
    Garcia HH
    Neurol Clin; 2018 Nov; 36(4):851-864. PubMed ID: 30366559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine-Associated Movement Disorder: A Literature Review.
    Rissardo JP; Fornari Caprara AL
    Neurol India; 2021; 69(6):1524-1538. PubMed ID: 34979637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second case of neurocysticercosis in a patient with liver transplantation (first case in Spain): a case report.
    Barra Valencia V; Moreno Elola-Olaso A; Fundora Suárez Y; Meneu Díaz JC; Jiménez de los Galanes SF; Pérez Saborido B; San Juan R; Ruiz Giménez J; Abradelo Usera M; Donat Garrido M; Gimeno Calvo A; Hernández Pérez MC; Jiménez Romero C; Moreno González E
    Transplant Proc; 2007 Sep; 39(7):2454-7. PubMed ID: 17889216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racemose neurocysticercosis.
    Krupa K; Krupa K; Pisculli ML; Athas DM; Farrell CJ
    Surg Neurol Int; 2016; 7():12. PubMed ID: 26958418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy.
    Bianchin MM; Velasco TR; Wichert-Ana L; Dos Santos AC; Sakamoto AC
    Epilepsy Behav; 2017 Nov; 76():168-177. PubMed ID: 28462844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocysticercosis as an infectious acquired epilepsy worldwide.
    Reddy DS; Volkmer R
    Seizure; 2017 Nov; 52():176-181. PubMed ID: 29055271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.